These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32828432)

  • 1. Design and synthesis of β-strand-fixed peptides inhibiting aggregation of amyloid β-protein.
    Tanaka F; Shibata K; Monobe Y; Akagi KI; Masuda Y
    Bioorg Med Chem; 2020 Sep; 28(18):115676. PubMed ID: 32828432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design and evaluation of β-sheet breaker peptides for destabilizing Alzheimer's amyloid-β
    Shuaib S; Narang SS; Goyal D; Goyal B
    J Cell Biochem; 2019 Oct; 120(10):17935-17950. PubMed ID: 31162715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both beta sheet breaker and alpha helix forming pentapeptide inhibits protein fibrillation: Implication for the treatment of amyloid disorders.
    Siddiqi MK; Majid N; Alam P; Malik S; Alam A; Rajan S; Ajmal MR; Khan RH
    Int J Biol Macromol; 2020 Jan; 143():102-111. PubMed ID: 31811850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-sheet breakers with consecutive phenylalanines: Insights into mechanism of dissolution of β-amyloid fibrils.
    Jarmuła A; Ludwiczak J; Stępkowski D
    Proteins; 2021 Jul; 89(7):762-780. PubMed ID: 33550630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mechanistic study of Aβ
    Sehra N; Parmar R; Maurya IK; Kumar V; Tikoo K; Jain R
    Bioorg Med Chem Lett; 2024 Nov; 112():129929. PubMed ID: 39151661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer's disease.
    Kaur A; Mann S; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
    Bioorg Chem; 2019 Jun; 87():572-584. PubMed ID: 30928879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
    Ghosh N; Kundu LM
    Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. d-Enantiomeric RTHLVFFARK-NH
    Liu W; Dong X; Sun Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,2,4-trihydroxynaphthalene-2-O-β-D-glucopyranoside delays amyloid-β
    Dhouafli Z; Leri M; Bucciantini M; Stefani M; Gadhoumi H; Mahjoub B; Ben Jannet H; Guillard J; Ksouri R; Saidani Tounsi M; Soto C; Hayouni EA
    Biofactors; 2018 May; 44(3):272-280. PubMed ID: 29582494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives.
    Dubey S; Kallubai M; Subramanyam R
    Int J Biol Macromol; 2021 Mar; 173():56-65. PubMed ID: 33465364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTHLVFFARK-NH
    Meng J; Zhang H; Dong X; Liu F; Sun Y
    J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-β aggregation: Molecular modeling and in vitro evaluation.
    Radwan AA; Alanazi FK; Raish M
    PLoS One; 2023; 18(5):e0286195. PubMed ID: 37228136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphic Aβ42 fibrils adopt similar secondary structure but differ in cross-strand side chain stacking interactions within the same β-sheet.
    Wang H; Duo L; Hsu F; Xue C; Lee YK; Guo Z
    Sci Rep; 2020 Mar; 10(1):5720. PubMed ID: 32235842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
    Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
    ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROSETTA-informed design of structurally stabilized cyclic anti-amyloid peptides.
    Est CB; Mangrolia P; Murphy RM
    Protein Eng Des Sel; 2019 Dec; 32(2):47-57. PubMed ID: 31650164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of Supramolecular β-Sheet and Nontoxic Amyloid Fibrils from Synthetic Oligopeptides Containing γ-Aminobutyric Acid as the N-Terminal Residue.
    Samui S; Biswas S; Roy K; Deb I; Naskar J
    ACS Chem Neurosci; 2019 Jun; 10(6):2915-2918. PubMed ID: 31082196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement.
    Morimoto A; Irie K; Murakami K; Masuda Y; Ohigashi H; Nagao M; Fukuda H; Shimizu T; Shirasawa T
    J Biol Chem; 2004 Dec; 279(50):52781-8. PubMed ID: 15459202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
    Li X; Wang W; Dong X; Sun Y
    J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.